Literature DB >> 18287190

Proposal for a patient database on cardiac interventional exposures for epidemiological studies.

M R Malisan1, R Padovani, K Faulkner, J F Malone, E Vaño, J Jankowski, A Kosunen.   

Abstract

Relatively high organ doses absorbed by patients in interventional cardiology suggest the opportunity to define these patients as a cohort to be followed forward in time in an epidemiological study of the cancer risks associated with exposure to low-dose ionising radiation. In this paper, the UNSCEAR 2000 Report risk estimates for the most exposed organs/tissues in cardiac interventional procedures are reviewed, as well as the critical features of such an epidemiological study that is anticipated to have an intrinsically low statistical power because of the low levels of risk and possible confounding factors. To overcome these limitations, data collected in different institutions can be combined provided that a common design and conduct are used for dose assessment. A minimum dataset to be collected on a patient basis is proposed that can be implemented routinely in most facilities. This data should be linked to the local patient information system in order to retrieve all the exposures of a given patient.

Entities:  

Mesh:

Year:  2008        PMID: 18287190     DOI: 10.1093/rpd/ncn036

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Follow-up of children exposed to ionising radiation from cardiac catheterisation: the Coccinelle study.

Authors:  H Baysson; B Nkoumazok; S Barnaoui; J L Réhel; B Girodon; G Milani; Y Boudjemline; D Bonnet; D Laurier; M O Bernier
Journal:  Radiat Prot Dosimetry       Date:  2015-04-01       Impact factor: 0.972

2.  Risk of cancer associated with cardiac catheterization procedures during childhood: a cohort study in France.

Authors:  Helene Baysson; Jean Luc Réhel; Younes Boudjemline; Jerôme Petit; Brigitte Girodon; Bernard Aubert; Dominique Laurier; Damien Bonnet; Marie-Odile Bernier
Journal:  BMC Public Health       Date:  2013-03-22       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.